The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Re value of Imutex;
I agree $300 to $500 valuation has been mentioned by CF previously but remember ORPH only own 49% so that has to be taken into account .
However not sure if the stage 1 Malaria drug is within the valuation. Might be extra.
Ok - thanks gents - I remember values of 300 m- 500m $ being bandied around. As you say Strictly even if its 50m, there is a significant windfall or SP rise in the offing. This alone should be flagged to investors.
there is a few videos of CF presentations out there - approx £300m but DYOR - THE £300M is CF best guess - no one actually know - so it's all guess work
I know this has been discussed previously, but does anyone have any further thoughts on the likely value of Imutex? I missed the webinar, but did CF mention anything else apart from a pre Xmas sale / listing ?
CF did say that some contracts will have $$ numbers attached. But some $$ will remain confidential, a lot will depend on the pharma and /or shape of the service being procured
Well said.... Stop complaining and put this stock away in the drawer and check on it around December. No need to stress yourself out. 4 months is fast if your not watching SP.
Anyone on the side lines? In my opinion now is a good time to pick up. As always DYOR
Will a trading update arrive out of the blue? I have been trying to figure out when the market is going to be informed with numbers.
The key to the SP is understanding the value of the contracts and revenue which we won't get until we get a trading update. I've now invested another £5k this morning taking me to 15k in total. Happy to wait to Xmas to see a rise. CF is fully invested and we are in a very niche market with a high demand for our services. Looking forward to the next few months. GLA
Great update last night by CF
It is very clear there is a shed load of value that is being unlocked here. CF was ultra confident on our direction of travel. We are profit making and growing strongly.
People need to stop bleating about the SP. But your shares away for 6 months then see where we are. This aint a covid double in 1 day stock. Nor will it deflate like a covid stock.
As investors or traders, we all have options. Nobody is holding a gun to your head